Bausch Health Companies Inc (BHC)

[maseraticoupe]

Comparison products info. From Stock house board.

Novartis Cosentyx generated sales of over $1 billion in 2016



Valeant's NEW psoriasis drug brodalumab, now branded as Siliq will generate anywhere from $250 million to $1 billion annually in the beginning...

Currently.. Valeant's Psoriasis drug is the cheapest out of all their competitors.

Novartis Cosentyx close to $46,000 for the first year treatment

Johnson & Johnson around $46,000 a year

Eli Lilly Talz over $50,000 for 1 year

Valeant's brodalumab (Siliq) .. only $42,000 a year ( THE LOWEST & THE CHEAPEST )


Let's look at Novartis Consentyx .. they start selling their drug in late 2015 and generated $261 million..... and in 2016 /// full year annual sales of Consentyx equals $1.1 BILLION.

Valeant sales in brodalumab (Siliq) will probably generate $350 million in the 2nd half of 2017... once more and more doctors and patients recognized the brand.... sales will really pick up in 2018..

I see Valeant's NEW psoriasis drug siliq could do $800 million to $1 billion in 2018

They already predicting Novartis Cosentyx to hit $5.7 billion in sales in 2024

Can you imagine Valeant's siliq doing $1 billion in 2018 ? and $2 billion in 2020 ??